SCHEMBL22327237

SCHEMBL22327237

CC(C)NCCNC(=O)c1cccc(OCC(C)(OCCOCS)SSC(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MAOB P27338 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ADRB2 P07550 1/20 0.36
▸ ADRB1 P08588 1/20 0.36
▸ ADRB3 P13945 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ F10 P00742 2/20 0.35
▸ TP53BP1 Q12888 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26049672 0.92 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1TAAR1LMNA
SCHEMBL24849637 0.92 ALDH1A1 (0.36) ALDH1A1KMT2AMEN1TAAR1LMNA
SCHEMBL26068748 0.91 MAPT (0.43) ALDH1A1KMT2AMEN1TAAR1LMNA
SCHEMBL24970907 0.91 KAT6A (0.38) ALDH1A1KMT2AMEN1TAAR1LMNA
SCHEMBL22327267 0.85 GAA (0.44) ALDH1A1KMT2AMEN1TAAR1MAOB
SCHEMBL22598234 0.85 MAOB (0.35) ALDH1A1KMT2AMEN1TAAR1LMNA
SCHEMBL24972998 0.84 GAA (0.42) ALDH1A1KMT2AMAOBGAAMAPT
SCHEMBL24849635 0.84 MAPT (0.41) ALDH1A1KMT2AMAOBGAAMAPT
SCHEMBL24972999 0.82 KAT6A (0.40) ALDH1A1KMT2AMEN1TAAR1LMNA
SCHEMBL25715347 0.82 ADRB2 (0.39) ALDH1A1KMT2AMEN1TAAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230193361-A1 METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING FIRST-CITIZENS BANK & TRUST COMPANY 2023-06-22 — — US disclosed
US-10738072-B1 Nucleotide analogues Singular Genomics Systems, Inc. (US) 2020-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738072-B1 Nucleotide analogues NUDT1, POLN, TYMP ALDH1A1 1629/4885KMT2A 2130/4885MEN1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback